| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210632 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 33 Pages |
Abstract
Capecitabine/MMC resulted in similar levels of grade 3/4 toxicity overall compared with 5-FU/MMC as CRT for ASCC, although differences were found in the patterns of observed toxicities, with less hematologic toxicity with capecitabine. Further studies of capecitabine/MMC are required to understand the acute toxicity profile and long-term oncologic outcomes of this combination with intensity modulated RT for ASCC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christopher M. MRCP, Richard FRCR, MD, Amy PhD, Rob FRCR, MD, Mark FRCR, PhD, Maria FRCR, MD, David FRCR, Duncan C. FRCR, PhD, Rebecca FRCR, MD,